Douglas R. Bradley

Vertos Medical, Inc. develops and markets minimally invasive devices for the treatment of lumbar spinal stenosis. Its product is called mild devices, which conists of mild Tissue Sculpter, mild Portal, mild Trocar and Handle, mild Bone Sculpter Rongeur, mild Portal Stabilizer, mild Depth Guide, and mild Surgical Clamp. The company was founded by David Solsberg and Donald F. Schomer in 2005 and is headquartered in Aliso Viejo, CA.

SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ.

Obagi Medical Products, Inc. develops, markets, and sells proprietary topical aesthetic and therapeutic prescription-strength skin care systems. It designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage and are primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. The company was founded in 1988 and is headquartered in Irvine, CA.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA.

Part of Boston Scientific Corp., Coherent Medical Group is a company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million.

Medical Marketing Association, Inc. provides tips, tools and tutorials for members to promote their business online. The company was founded in 2007 and is headquartered in Bethlehem, PA.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.